law://eu/reg/2018/1129@2026-11-14THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsnote, and in particular the third subparagraph of Article 89(1) thereof,Whereas:
HAS ADOPTED THIS REGULATION:
| Common Name | IUPAC NameIdentification Numbers | Minimum degree of purity of the active substancenote | Date of approval | Expiry date of approval | Product type | Specific conditions |
|---|---|---|---|---|---|---|
| Acetamiprid | IUPAC Name:(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamideEC No: NoneCAS No: 135410-20-7 | 99,0 % w/w | 1 February 2020 | 31 January 2027 | 18 | Acetamiprid is considered a candidate for substitution in accordance with point (d) of Article 10(1) of Regulation (EU) No 528/2012.The authorisations of biocidal products are subject to the following conditions:1. The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.2. In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to: (a)professional users;(b)infants and toddlers following secondary exposure when the product is sprayed by professionals;(c)surface water, sediment, soil, groundwater for products applied by spray or brush in stables;(d)surface water, sediment, soil, groundwater for products applied by spray outdoors.3. For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council or Regulation (EC) No 396/2005 of the European Parliament and of the Council shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.The placing on the market of treated articles is subject to the following condition:The person responsible for the placing on the market of a treated article treated with or incorporating acetamiprid shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012. |
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.